Long Term Safety Assessment of SER120 in Patients With Nocturia

NCT00981682 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia

Interventions

DRUG: SER120

Sponsor

Serenity Pharmaceuticals, Inc.